Cargando…
Study on the progression types of cancer in patients with breast cancer undergoing eribulin chemotherapy and tumor microenvironment
BACKGROUND: Recently, the concepts of progression due to pre-existing lesions (PPL) and progression due to new metastasis (PNM) have been proposed to differentiate the progression types of treatment-resistant cancers. Previously, the differences between these two progression types did not affect the...
Autores principales: | Kashiwagi, Shinichiro, Tsujio, Gen, Asano, Yuka, Goto, Wataru, Takada, Koji, Takahashi, Katsuyuki, Morisaki, Tamami, Fujita, Hisakazu, Takashima, Tsutomu, Tomita, Shuhei, Ohsawa, Masahiko, Hirakawa, Kosei, Ohira, Masaichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845371/ https://www.ncbi.nlm.nih.gov/pubmed/29523158 http://dx.doi.org/10.1186/s12967-018-1443-5 |
Ejemplares similares
-
Inhibitory effects of iron depletion plus eribulin on the breast cancer microenvironment
por: Goto, Wataru, et al.
Publicado: (2020) -
Prediction of treatment responses to neoadjuvant chemotherapy in triple-negative breast cancer by analysis of immune checkpoint protein expression
por: Asano, Yuka, et al.
Publicado: (2018) -
Use of Tumor-infiltrating lymphocytes (TILs) to predict the treatment response to eribulin chemotherapy in breast cancer
por: Kashiwagi, Shinichiro, et al.
Publicado: (2017) -
Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ
por: Takada, Koji, et al.
Publicado: (2020) -
Novel evaluation scale for QOL (QOL-ACD-BP) in preoperative chemotherapy for breast cancer
por: Takada, Koji, et al.
Publicado: (2018)